Article Text

Epidemiology and Genetics of Calcific Aortic Valve Disease
  1. Kevin D. O'Brien
  1. From the Division of Cardiology, University of Washington, Seattle, WA.
  1. Address correspondence to: Dr. Kevin D. O'Brien, Division of Cardiology, Box 356422, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195-6422; e-mail: cardiac{at}


Calcific aortic valve disease is a common condition in the elderly and is associated with significant morbidity and mortality. Although biologically plausible roles in disease pathogenesis have been proposed for both lipoproteins and the renin-angiotensin system, no properly controlled, randomized trials have demonstrated that any pharmacologic therapy slows development of the disease. This review defines the stages of calcific aortic valve disease; discusses the role of nonechocardiographic techniques, such as cardiac computed tomography, that may allow identification and study of earlier-stage disease; reviews associated epidemiologic factors; and summarizes recent studies of “novel” risk factors, such as metabolic syndrome and inflammatory biomarkers. Finally, the role of genetics in this disease is receiving greater attention, and recent studies are reviewed that examine genetic polymorphisms and identify single-gene defects associated with this disease. Together these latter sets of studies emphasize that unique “nonatherosclerotic” factors can influence calcific aortic valve disease development, suggesting the possibility of novel therapeutic strategies for this condition.

Key words
  • aortic valve disease
  • risk factors
  • computed tomography
  • echocardiography
  • genetics
  • genomics

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.